Zhittya Genesis Medicine dismissed from CVBT's Lawsuit
Cardiovascular Biohtherapeutics' lawsuit claiming that Zhittya Genesis Medicine stole Intellectual Property (IP) from CVBT/Venturis Therapeutics has been dismissed by the Nevada State Court, forcing CVBT/VT to acknowledge that Zhittya Genesis Medicine owns all of the IP it is now developing.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.